Proximal Aortopathy in Scotland - Epidemiology and Surgical Outcomes
An Investigation Into the Epidemiology and Surgical Intervention for Proximal Aortic Disease in Scotland
1 other identifier
observational
1,662
1 country
1
Brief Summary
The aorta is the principal arterial vessel arising from the left heart that transfers blood to the body. Certain genetic and familial disease processes are known to weaken the aortic wall resulting in dilation and potential rupture. These aortic complications carry high mortality (\>25%) and current management is orientated towards early detection and preventive treatment. Aortic dilation can also result in aortic valve dysfunction leading to heart failure. The estimated UK incidence of aortic disease per year is around 10 per 100,000 individuals, with 2000 people per year dying from aortic complications. The 2017-2020 National Adult Cardiac Surgery Audit report identified the number of people receiving surgery for aortic dissection in Scotland is per population proportionately lower compared to England (4.6 per million per year in Scotland vs. 6.6 per million per year in England). The reasons for this are unclear but may relate to the prevalence of aortic disease or a large geographic distribution with compromised access to specialized centres. Currently surgery is recommended when the aortic diameter exceeds a certain threshold. There are several types of effective surgical procedures, but there is still limited information on their long-term outcomes and the advantage of one procedure over another. The aims of the project are firstly to determine the clinical outcomes of the surgical procedures that are currently employed in Scotland to treat proximal aortic disease and secondly to describe the prevalence and distribution of proximal aortic disease within the Scottish population. The project will be hosted by the Golden Jubilee Research Institute. Contemporary and retrospective data will be collected from all the Scottish Cardiothoracic Surgery units which are based in Glasgow, Edinburgh and Aberdeen. This will be the first study to analyse surgical outcomes for ascending aortic disease in Scotland, and the first to describe the epidemiology of aortic disease within the population. It is anticipated that the results will guide current surgical practise, and provide data to inform national service provision for the management of proximal aortic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
December 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 15, 2024
July 1, 2024
1.6 years
May 6, 2022
July 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Early survival following surgery of the proximal aorta
In-hospital or 30 days survival following surgery of the proximal aorta
In-hospital or 30 days (whichever is longer)
Late survival following surgery of the proximal aorta
Long-term survival following surgery of the proximal aorta
5 years or latest available follow-up (whichever is longer)
Patient demographics and geographic distribution of thoracic aortopathy within the Scottish population
Identify the demographics (age, gender, relevant risk factors) and geographic distribution (area codes) of patients diagnosed with thoracic aortopathy within the Scottish population
Cross-sectional analysis (2011-2021)
Secondary Outcomes (5)
Cardiovascular reintervention
1 year or latest available follow-up (whichever is longer)
Specified adverse events following surgery
1 year or latest available follow-up (whichever is longer)
Left ventricular ejection fraction (LVEF) following surgery
1 year or latest available follow-up (whichever is longer)
Aortic valve mean gradient and degree of regurgitation following surgery
1 year or latest available follow-up (whichever is longer)
Genotypes and phenotypes prevalent in the Scottish population
Previous 5 years
Study Arms (2)
Surgical cohort
Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen.
Non-surgical cohort
\- Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.
Interventions
Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)
Radiological size criteria or Genetic mutations associated with aortopathies
Eligibility Criteria
1. Surgical cohort (Observational cohort design)- Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen. 2. Non-surgical cohort (Cross-sectional design) - Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.
You may qualify if:
- all adults (\>18 years of age) that underwent surgical intervention on the proximal aorta in Scotland between 2008 and 2021.
You may not qualify if:
- Isolated surgery on the descending thoracic aorta
- Non-surgical cohort
- \- all adult patients (\>18 years of age) with a radiological, genetic or post-mortem diagnosis of thoracic aortic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Golden Jubilee National Hospitallead
- Aberdeen Royal Infirmarycollaborator
- Royal Infirmary of Edinburghcollaborator
- Network for Inherited Cardiac Conditions Scotlandcollaborator
- University of Glasgowcollaborator
Study Sites (1)
Golden Jubilee National Hospital
Glasgow, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George Gradinariu, MD
Golden Jubilee National Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Cardiothoracic Surgery Specialty Registrar
Study Record Dates
First Submitted
May 6, 2022
First Posted
May 25, 2022
Study Start
December 18, 2023
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
July 15, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
To apply for further studies, beyond the current research, using the existing dataset, a research proposal submitted to the GJNH Research Department will be required. This will follow the established internal peer-review process established by the GJNH research department. If approved, a data request form will need to be submitted to the data custodian who will release the pseudo- anonymised data to the research applicant. If there is no request to extend the study then this data will be deleted.